Mosaic ImmunoEngineering (CPMV) Gross Margin (2010 - 2011)
Mosaic ImmunoEngineering (CPMV) posted quarterly Gross Margin of 74.13% for Q4 2011, up 7566.0% year-over-year from 0.97% in Q4 2010, and down 1.71% quarter-over-quarter from 75.41% in Q3 2011.
Mosaic ImmunoEngineering (CPMV) Gross Margin (2010 - 2011) Analysis & Trends
Mosaic ImmunoEngineering's Gross Margin history runs 2 years deep, the most recent figure standing at 74.13% for Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 76.90% |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | 63.27% |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 84.20% |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | - |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2011 | 74.13% |
| Aug 31, 2011 | 75.41% |
| Nov 30, 2010 | -1.53% |
| Aug 31, 2010 | 1.86% |